Vistin Pharma ASA: Mandatory notification of trade
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA. Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are sold to one of Pactum’s shareholders, as part of a share buy-back process in Pactum.
After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma ASA.
Please see attached document in accordance with the Market Abuse Regulation article 19.
This notification has been submitted pursuant to the Securities Trading Act section 5-12.
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carhartt Data Breach: Ademi LLP Investigates Claims for Damages
- Encrypted Phone Vault Vaultaire Makes Client-Side Cloud Backup Free for Every User
- SWE90 Offers Fiduciary Advisory and Brokerage Services in California
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share